Page last updated: 2024-09-04

cilomilast and colforsin

cilomilast has been researched along with colforsin in 2 studies

Compound Research Comparison

Studies (cilomilast)	Trials (cilomilast)	Recent Studies (post-2010) (cilomilast)	Studies (colforsin)	Trials (colforsin)	Recent Studies (post-2010) (colforsin)
162	13	42	13,460	46	1,298

Protein Interaction Comparison

Protein	Taxonomy	colforsin (IC50)
nuclear receptor subfamily 0 group B member 1	Homo sapiens (human)	1.729
5-hydroxytryptamine receptor 1A	Homo sapiens (human)	0.041
Adenylate cyclase type 1	Homo sapiens (human)	0.0955

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ammit, AJ; Amrani, Y; Hay, DW; Hoffman, RK; Lazaar, AL; Panettieri, RA; Penn, RB; Torphy, TJ	1
Ezeamuzie, CI	1

Other Studies

2 other study(ies) available for cilomilast and colforsin

Article	Year
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. American journal of respiratory cell and molecular biology, 2000, Volume: 23, Issue:6 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bucladesine; Cells, Cultured; Chemokine CCL5; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Humans; Interleukin-6; Muscle, Smooth; NF-kappa B; Nitriles; Phosphodiesterase Inhibitors; RNA, Messenger; Time Factors; Trachea; Transcription, Genetic; Tumor Necrosis Factor-alpha	2000
Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors. European journal of pharmacology, 2001, Apr-06, Volume: 417, Issue:1-2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline	2001

Article

Year

Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate.

American journal of respiratory cell and molecular biology, 2000, Volume: 23, Issue:6

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bucladesine; Cells, Cultured; Chemokine CCL5; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Humans; Interleukin-6; Muscle, Smooth; NF-kappa B; Nitriles; Phosphodiesterase Inhibitors; RNA, Messenger; Time Factors; Trachea; Transcription, Genetic; Tumor Necrosis Factor-alpha

2000

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.

European journal of pharmacology, 2001, Apr-06, Volume: 417, Issue:1-2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline

2001